Published in Eur Heart J on May 01, 2004
Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation (2010) 5.70
CPAP versus oxygen in obstructive sleep apnea. N Engl J Med (2014) 2.75
Epidemiology of Obstructive Sleep Apnea: a Population-based Perspective. Expert Rev Respir Med (2008) 1.94
Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. J Clin Sleep Med (2008) 1.38
Impact of sleep on arrhythmogenesis. Circ Arrhythm Electrophysiol (2009) 1.34
Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea. J Thorac Dis (2015) 1.32
Mechanisms of cardiac dysfunction in obstructive sleep apnea. Nat Rev Cardiol (2012) 1.22
Effectiveness of lifestyle interventions on obstructive sleep apnea (OSA): systematic review and meta-analysis. Sleep (2013) 1.20
Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers - a meta-analysis. J Inflamm (Lond) (2013) 1.15
Control of sympathetic vasomotor tone by catecholaminergic C1 neurones of the rostral ventrolateral medulla oblongata. Cardiovasc Res (2011) 1.06
Sleep-disordered breathing and cardiovascular disorders. Respir Care (2010) 1.06
Severe obstructive sleep apnea and outcomes following myocardial infarction. J Clin Sleep Med (2011) 1.06
Assessment of multiple health risks in a single obstructive sleep apnea population. J Clin Sleep Med (2012) 1.05
Cardiovascular disease risk reduction with sleep apnea treatment. Expert Rev Cardiovasc Ther (2010) 0.99
Sleep apnea in rheumatoid arthritis patients with occipitocervical lesions: the prevalence and associated radiographic features. Eur Spine J (2009) 0.98
Prognosis and cardiovascular morbidity and mortality in prospective study of hypertensive patients with obstructive sleep apnea syndrome in St Petersburg, Russia. Med Sci Monit (2011) 0.97
Do rheumatoid arthritis patients have a higher risk for sleep apnea? J Rheumatol (2009) 0.96
Heavy snoring is a risk factor for case fatality and poor short-term prognosis after a first acute myocardial infarction. Sleep (2008) 0.95
Prevalence of Undetected Sleep Apnea in Patients Undergoing Cardiovascular Surgery and Impact on Postoperative Outcomes. J Clin Sleep Med (2015) 0.93
Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes. Eur Heart J (2004) 0.91
Sleep Apnea Cardiovascular Clinical Trials-Current Status and Steps Forward: The International Collaboration of Sleep Apnea Cardiovascular Trialists. Sleep (2013) 0.91
The importance of sleep-disordered breathing in cardiovascular disease. Clin Res Cardiol (2015) 0.90
Obstructive sleep apnea and cardiovascular disease in blacks: a call to action from the Association of Black Cardiologists. Am Heart J (2013) 0.89
Obstructive sleep apnea and coronary artery disease: from pathophysiology to clinical implications. Pulm Med (2013) 0.89
Functional outcomes in patients with REM-related obstructive sleep apnea treated with positive airway pressure therapy. J Clin Sleep Med (2012) 0.89
Impact of obstructive sleep apnea on the occurrence of restenosis after elective percutaneous coronary intervention in ischemic heart disease. Respir Res (2008) 0.87
Role of sleep quality in the metabolic syndrome. Diabetes Metab Syndr Obes (2016) 0.86
Obstructive sleep apnoea syndrome and its management. Ther Adv Chronic Dis (2015) 0.84
Epidemiological and Pathogenic Relationship between Sleep Apnea and Ischemic Heart Disease. Pulm Med (2013) 0.84
OSA: the new cardiovascular disease: part II: Overview of cardiovascular diseases associated with obstructive sleep apnea. Heart Fail Rev (2008) 0.84
Cardiac response to chronic intermittent hypoxia with a transition from adaptation to maladaptation: the role of hydrogen peroxide. Oxid Med Cell Longev (2012) 0.83
Death and disability in patients with sleep apnea--a meta-analysis. Arq Bras Cardiol (2014) 0.83
Circadian variability of fibrinolytic markers and endothelial function in patients with obstructive sleep apnea. Sleep (2014) 0.82
Obstructive sleep apnoea as a risk factor for atherosclerosis - implication for preventive and personalised treatment. EPMA J (2011) 0.81
Continuous positive airway pressure treatment improves cardiovascular outcomes in elderly patients with cardiovascular disease and obstructive sleep apnea. Heart Vessels (2013) 0.81
Cardiac effects of continuous and bilevel positive airway pressure for patients with heart failure and obstructive sleep apnea: a pilot study. Chest (2008) 0.81
A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease. Vasc Health Risk Manag (2016) 0.80
Treatment of OSA reduces the risk of repeat revascularization after percutaneous coronary intervention. Chest (2015) 0.80
Sleep: important considerations for the prevention of cardiovascular disease. Curr Opin Cardiol (2016) 0.79
Metabolic syndrome and sleep apnea. Hippokratia (2008) 0.78
Established vascular effects of continuous positive airway pressure therapy in patients with obstructive sleep apnoea-an update. J Thorac Dis (2015) 0.78
Sleep-disordered breathing and cardiovascular disease. Indian Heart J (2015) 0.78
Interactive associations of depression and sleep apnea with adverse clinical outcomes after acute myocardial infarction. Psychosom Med (2012) 0.78
Obstructive sleep apnea - management update. Neuropsychiatr Dis Treat (2006) 0.77
High prevalence of poststroke sleep-disordered breathing in Mexican Americans. Sleep Med (2016) 0.75
Correlates of Pediatric CPAP Adherence. J Clin Sleep Med (2016) 0.75
A Narrative Review of How Sleep-Related Breathing Disorders and Cardiovascular Diseases Are Linked: An Update for Advanced Practice Registered Nurses. Clin Nurse Spec (2016) 0.75
Sleep disorder and cardiovascular risk factors in type 2 diabetes mellitus. Korean J Intern Med (2011) 0.75
Sleep apnoea is common in severe peripheral arterial disease. PLoS One (2017) 0.75
The revised Ghent nosology for the Marfan syndrome. J Med Genet (2010) 6.87
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet (2012) 6.42
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2007) 6.34
Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet (2004) 6.15
Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation (2003) 5.85
Current epidemiology of septic shock: the CUB-Réa Network. Am J Respir Crit Care Med (2003) 4.71
Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med (2008) 3.85
Increased mortality among patients taking digoxin--analysis from the AFFIRM study. Eur Heart J (2012) 3.52
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 3.50
Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol (2007) 3.09
Influence of ICU case-volume on the management and hospital outcomes of acute exacerbations of chronic obstructive pulmonary disease*. Crit Care Med (2013) 2.75
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail (2010) 2.64
Mortality among patients admitted to intensive care units during weekday day shifts compared with "off" hours. Crit Care Med (2007) 2.53
TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat Genet (2012) 2.50
A patient-based national survey on postoperative pain management in France reveals significant achievements and persistent challenges. Pain (2008) 2.31
Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation (2011) 2.17
Isolated left ventricular non-compaction in adults: clinical and echocardiographic features in 105 patients. Results from a French registry. Eur J Heart Fail (2010) 2.04
Use of transthoracic echocardiography combined with venous ultrasonography in patients with pulmonary embolism. Int J Cardiol (2004) 1.97
Prevalence and characteristics of left ventricular outflow tract obstruction in Tako-Tsubo syndrome. Am Heart J (2008) 1.93
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. JAMA (2007) 1.91
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J Am Coll Cardiol (2013) 1.89
Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J Crit Care (2002) 1.78
Low stretch ventilation strategy in acute respiratory distress syndrome: eight years of clinical experience in a single center. Crit Care Med (2003) 1.76
Prevalence, characteristics, and outcomes of patients presenting with cardiogenic unilateral pulmonary edema. Circulation (2010) 1.75
Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway. J Pathol (2009) 1.74
Cardiovascular manifestations in men and women carrying a FBN1 mutation. Eur Heart J (2010) 1.68
A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J (2011) 1.67
Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations. Pediatrics (2009) 1.67
Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction. Eur Heart J (2012) 1.66
Incidence and impact of organ dysfunctions associated with sepsis. Chest (2005) 1.58
Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med (2012) 1.58
Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up. Eur Heart J (2008) 1.54
Improved prognosis of septic shock in patients with cirrhosis: a multicenter study*. Crit Care Med (2014) 1.52
Long-term developmental follow-up of infants who participated in a randomized clinical trial of amniocentesis vs laser photocoagulation for the treatment of twin-to-twin transfusion syndrome. Am J Obstet Gynecol (2010) 1.51
Usefulness of contrast echocardiography for assessment of intracardiac masses. Arch Cardiovasc Dis (2009) 1.51
Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect. Eur J Heart Fail (2003) 1.46
Intensive care unit renal support therapy volume is not associated with patient outcome. Crit Care Med (2011) 1.42
Management of atrial fibrillation in heart failure in the elderly. Int J Cardiol (2007) 1.42
Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace (2010) 1.40
Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections. Am J Hum Genet (2013) 1.40
Serial echocardiographic assessment of left ventricular mass: how blinded should readers be? J Hypertens (2004) 1.38
Genetic association study identifies HSPB7 as a risk gene for idiopathic dilated cardiomyopathy. PLoS Genet (2010) 1.37
Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med (2007) 1.34
Treatment intensity and outcome of patients aged 80 and older in intensive care units: a multicenter matched-cohort study. J Am Geriatr Soc (2005) 1.31
Natural history of progressive adult scoliosis. Spine (Phila Pa 1976) (2007) 1.26
Variants of the MATP/SLC45A2 gene are protective for melanoma in the French population. Hum Mutat (2008) 1.26
Echo-Doppler demonstration of acute cor pulmonale at the bedside in the medical intensive care unit. Am J Respir Crit Care Med (2002) 1.23
Nomograms for aortic root diameters in children using two-dimensional echocardiography. Am J Cardiol (2010) 1.23
Validation of a skills assessment scoring system for transesophageal echocardiographic monitoring of hemodynamics. Intensive Care Med (2007) 1.22
Efficacy of therapeutic hypothermia after out-of-hospital cardiac arrest due to ventricular fibrillation. Resuscitation (2007) 1.21
Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation (2009) 1.21
Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes. Ann Surg Oncol (2012) 1.18
Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders. Hum Mutat (2008) 1.14
Molecular genetics of Marfan syndrome. Curr Opin Cardiol (2005) 1.13
The FBN2 gene: new mutations, locus-specific database (Universal Mutation Database FBN2), and genotype-phenotype correlations. Hum Mutat (2009) 1.11
Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco Programme. Eur J Heart Fail (2009) 1.11
Variability of intensive care admission decisions for the very elderly. PLoS One (2012) 1.10
Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fibrillation. Crit Care (2011) 1.10
Identification of the minimal combination of clinical features in probands for efficient mutation detection in the FBN1 gene. Eur J Hum Genet (2009) 1.09
Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis. Eur Heart J (2007) 1.09
How to evaluate and improve the reliability of power Doppler ultrasonography for assessing enthesitis in spondylarthritis. Arthritis Rheum (2009) 1.08
Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome. Arch Cardiovasc Dis (2010) 1.08
Bone mineral density in Marfan syndrome. A large case-control study. Joint Bone Spine (2006) 1.07
Clinical utility gene card for: Loeys-Dietz syndrome (TGFBR1/2) and related phenotypes. Eur J Hum Genet (2011) 1.07
Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms. Cardiovasc Res (2010) 1.07
Hemodynamic instability in sepsis: bedside assessment by Doppler echocardiography. Am J Respir Crit Care Med (2003) 1.05
Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study. Eur J Heart Fail (2012) 1.04
Prognosis factors in probands with an FBN1 mutation diagnosed before the age of 1 year. Pediatr Res (2011) 1.04
Aortic dilatation patterns and rates in adults with bicuspid aortic valves: a comparative study with Marfan syndrome and degenerative aortopathy. Heart (2013) 1.02
The OMERACT ultrasound task force--status and perspectives. J Rheumatol (2011) 1.01
Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS). Am Heart J (2005) 1.01
Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis with multiple organ failure. Int J Technol Assess Health Care (2006) 1.01
How to diagnose spondyloarthritis early? Accuracy of peripheral enthesitis detection by power Doppler ultrasonography. Ann Rheum Dis (2011) 1.01
Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome. Am J Cardiol (2006) 1.00
The COASST study: cost-effectiveness of albumin in severe sepsis and septic shock. J Crit Care (2007) 0.98
Assessment of patent foramen ovale in carcinoid heart disease. Am Heart J (2006) 0.96
Breathing-swallowing interaction in neuromuscular patients: a physiological evaluation. Am J Respir Crit Care Med (2006) 0.96
Progression to rheumatoid arthritis in early inflammatory arthritis is associated with low IL-7 serum levels. Ann Rheum Dis (2012) 0.95
Dissection in Marfan syndrome: the importance of the descending aorta. Eur Heart J (2010) 0.94
In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome. Am J Hum Genet (2012) 0.94
Efficacy and cost of home-initiated auto-nCPAP versus conventional nCPAP. Sleep (2003) 0.93
The OMERACT ultrasound task force -- Advances and priorities. J Rheumatol (2009) 0.93
Usefulness of contrast echocardiography for assessment of left ventricular thrombus after acute myocardial infarction. Am J Cardiol (2007) 0.93
De novo 15q21.1q21.2 deletion identified through FBN1 MLPA and refined by 244K array-CGH in a female teenager with incomplete Marfan syndrome. Eur J Med Genet (2010) 0.92
Heart rate per se impacts cardiac function in patients with systolic heart failure and pacing: a pilot study. Eur J Heart Fail (2009) 0.92
Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF). Eur J Heart Fail (2008) 0.92
Early veno-venous haemodiafiltration for sepsis-related multiple organ failure. Crit Care (2005) 0.90
Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. J Hypertens (2005) 0.90
Routine prone positioning in patients with severe ARDS: feasibility and impact on prognosis. Intensive Care Med (2011) 0.89
Computed tomography scanning facilitates the diagnosis of sacroiliitis in patients with suspected spondylarthritis: results of a prospective multicenter French cohort study. Arthritis Rheum (2012) 0.88
Cancer-related symptom assessment in France: validation of the French M. D. Anderson Symptom Inventory. J Pain Symptom Manage (2010) 0.88